Healthcare cos see a Covid lining, line up to raise record money
Pune-based Emcure Pharmaceuticals, a generic drug maker has initiated plans for Rs 3,500-4,000 crore IPO and is consulting investment bankers to start work on documentation.
Synopsis
At least 12 drug makers and healthcare companies are planning IPOs in 2021 as the pandemic increases investor demand for the promising players in related sectors
Mumbai: India’s primary market is likely to witness record fund raising by pharma, healthcare and related companies in 2021 as investors scout for firms that could benefit from the Covid-19 pandemic. Initial public offerings of at least 12 drug makers and healthcare companies are in the offing in 2021, according to bankers. In the past five years, only seven companies involved in the sector have hit the IPO market.
These companies are in
